THE PROTEOGLYCAN DECORIN BINDS C1Q AND INHIBITS THE ACTIVITY OF THE C1 COMPLEX

被引:0
|
作者
KRUMDIECK, R
HOOK, M
ROSENBERG, LC
VOLANAKIS, JE
机构
[1] UNIV ALABAMA, DEPT MED, DIV CLIN IMMUNOL & RHEUMATOL, BIRMINGHAM, AL 35294 USA
[2] MONTEFIORE MED CTR, ORTHOPED RES LABS, BRONX, NY 10467 USA
来源
JOURNAL OF IMMUNOLOGY | 1992年 / 149卷 / 11期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Decorin, a small collagen-binding dermatan sulfate proteoglycan, is widely distributed as a component of extracellular matrices. Using a solid phase binding assay, we showed that decorin bound C1q at physiologic pH and ionic strength. The interaction did not require divalent cations and was time and temperature dependent reaching equilibrium in 4 h at 37-degrees-C. Binding was specific and saturable with an apparent dissociation constant of 7.6 x 10(-9) M. Decorin was shown to bind pepsin-derived fragments containing the collagenous domain of C1q and collagenase-derived fragments containing the globular domain of C1q. Because these fragments share a short sequence of amino acids, this finding suggests that decorin binds to a region of C1q located near the junction of the two domains. Competition studies using purified preparations of the decorin core protein and the glycosaminoglycan chains showed that only the former inhibited binding of decorin to C1q indicating that the interaction is mediated by the decorin core protein. Decorin was shown to inhibit the hemolytic activity of purified C1 as well as C1 in normal human serum. Approximately 50% inhibition was observed at a decorin concentration of 2 mug/ml. Inhibition was not observed if C1 was bound to Ag-complexed antibody. Furthermore, neither the core protein nor the glycosaminoglycan chain of decorin inhibited C1, indicating that the intact proteoglycan is necessary for functional activity.
引用
收藏
页码:3695 / 3701
页数:7
相关论文
共 50 条
  • [41] Angioedema with normal C1q and C1 inhibitor: an atypical presentation of Waldenström macroglobulinemia
    Anas Khanfar
    Anita Trikha
    Rana Bonds
    Bagi Jana
    International Journal of Hematology, 2013, 97 : 654 - 656
  • [42] C1Q inhibits autoantibody binding to calreticulin.
    Racila, D
    Sontheimer, RD
    FASEB JOURNAL, 1998, 12 (04): : A608 - A608
  • [43] IMMUNOCHEMICAL AND FUNCTIONAL ANALYSES OF A COMPLETE C1Q DEFICIENCY IN MAN - EVIDENCE THAT C1R AND C1S ARE IN THE NATIVE FORM, AND THAT THEY REASSOCIATE WITH PURIFIED C1Q TO FORM MACROMOLECULAR C1
    LOOS, M
    LAURELL, AB
    SJOHOLM, AG
    MARTENSSON, U
    BERKEL, AI
    JOURNAL OF IMMUNOLOGY, 1980, 124 (01): : 59 - 63
  • [44] THE C1Q RECEPTOR
    ERDEI, A
    REID, KBM
    MOLECULAR IMMUNOLOGY, 1988, 25 (11) : 1067 - 1073
  • [45] Heterogeneity of C1q autoantibodies in patients with low concentrations of circulating C1q
    Mårtensson, U
    Sturfelt, G
    Sjöholm, AG
    MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 109 - 110
  • [46] Localisation of the C1q binding site within C1q receptor/calreticulin
    Stuart, GR
    Lynch, NJ
    Lu, J
    Geick, A
    Moffatt, BE
    Sim, RB
    Schwaeble, WJ
    FEBS LETTERS, 1996, 397 (2-3): : 245 - 249
  • [47] Membranous nephropathy with predominance of C1q: another variant of C1q nephropathy?
    den Deurwaarder, E. S. G.
    Steenbergen, E. J.
    Hoogeveen, E. K.
    Wetzels, J. F. M.
    CLINICAL NEPHROLOGY, 2012, 77 (06) : 501 - 504
  • [48] IDENTIFICATION OF THE ACTIVE COMPONENT OF SERUM C1Q INHIBITOR (C1Q INH)
    BOSSONE, SA
    GHEBREHIWET, B
    FASEB JOURNAL, 1988, 2 (06): : A1833 - A1833
  • [49] OXIDATION OF C1Q WITH CHLORAMINE-T - COMPARISON WITH NORMAL C1Q
    ENGLER, H
    SPATH, PJ
    BUTLER, R
    EXPERIENTIA, 1984, 40 (06): : 605 - 605
  • [50] SIMILARITIES BETWEEN MACROPHAGE-DERIVED C1Q AND SERUM C1Q
    LOOS, M
    RABS, U
    HITSCHOLD, T
    GOLAN, MD
    IMMUNOBIOLOGY, 1983, 164 (3-4) : 271 - 272